Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Future MRI tools in multiple sclerosis.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Effects of magnetization transfer on T1 contrast in human brain white matter.
Autonomic dysfunction in multiple sclerosis.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Sexual function in women with multiple sclerosis.
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
Robotic therapy: the tipping point.
A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis.
The Link between CD6 and Autoimmunity: Genetic and Cellular Associations.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
Upper limb functional electrical stimulation devices and their man-machine interfaces.
[Current state of research on multiple sclerosis].
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
CX3CR1 in multiple sclerosis.

Pages